Horizon Pharma (HZNP)

Add to Watchlists
Create an Alert
25.97 +0.00  +0.00% NASDAQ Apr 1, 12:54PM BATS Real time Currency in USD
View Full Chart
HZNP Price Chart
View All Events

HZNP Events

Date Type Description
02/27/2015 08:00 EST Misc Horizon Pharma PLC Fourth Quarter Earnings Conference Call in 2014
02/27/2015 Earnings Horizon Pharma PLC Fourth Quarter Earnings in 2014 Release
02/12/2015 15:05 EST Misc 2015 Leerink Global Healthcare Conference
02/10/2015 13:30 EST Misc 17th Annual BIO CEO & Investor Conference
11/06/2014 08:00 EST Misc Q3 2014 Horizon Pharma Inc Earnings Conference Call
11/06/2014 Earnings Q3 2014 Horizon Pharma Inc Earnings Results
10/13/2014 17:00 EDT Misc Friedreich's Ataxia Analyst Day
08/07/2014 08:00 EDT Misc Q2 2014 Horizon Pharma Inc Earnings Conference Call
08/07/2014 Earnings Q2 2014 Horizon Pharma Inc Earnings Results
05/09/2014 08:00 EDT Misc Q1 2014 Horizon Pharma Inc Earnings Conference Call
View All Performance Charts

HZNP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Horizon Pharma is up 71.76% over the last year vs S&P 500 Total Return up 12.18%, Teva Pharmaceutical Indus up 20.55%, and ANI Pharmaceuticals up 102.5%.

Get Quote for

PDF Report for HZNP

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download HZNP Pro Report PDF
Advertisement

Portfolio Strategies Featuring HZNP

Did Horizon Pharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

HZNP Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Company Website: http://www.horizonpharma.com
  • IR Website: http://ir.horizon-pharma.com/
  • HQ Country: Ireland
  • HQ State/Province: N/A
  • Incorporation Country: Ireland
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Horizon Pharma PLC is a specialty pharmaceutical company. The Company’s product portfolio consists of ACTIMMUNE, DUEXIS, PENNSAID 2% and RAYOS/LODOTRA, which addresses the unmet therapeutic needs in arthritis, pain, inflammatory and/or orphan diseases.

HZNP Excel Add-In Codes

  • Name: =YCI("HZNP","name")
  • Description: =YCI("HZNP","description")
  • Sector: =YCI("HZNP","sector")
  • Industry: =YCI("HZNP","industry")
  • Est. Current Fiscal Year End: =YCI("HZNP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.